TrialPath
ALS (Lou Gehrig's disease) · New York

ALS (Lou Gehrig's disease) clinical trials in New York

2 recruiting amyotrophic lateral sclerosis studies within range of New York. Click any trial for full eligibility criteria and contact info.

NYSCF Scientific Discovery Biobank

Recruiting

The New York Stem Cell Foundation (NYSCF) Research Institute is performing this research to accelerate diverse disease research using cells from the body (such as skin or blood cells) to make stem cells and other types of cells, conduct research on the samples, perform genetic testing, and store the samples for future use. Through this research, researchers hope to identify future treatments or even cures for the major diseases of our time.

Phase—
TypeObservational
Age30 Days
WhereNew York, New York, United States
SponsorNew York Stem Cell Foundation Research Institute
▾Tap for details
Apply

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

NCT07002034 · Adjustment Disorder
Recruiting

The purpose of this study is to determine if treatment with a single dose of RE104 for Injection reduces depressive symptoms or depressive symptoms mixed with anxiety symptoms in participants with Adjustment Disorder due to cancer or other illnesses such as Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), Parkinson's Disease (PD) or Idiopathic Pulmonary Fibrosis (IPF) as compared to active-placebo.

PhasePhase 2
TypeInterventional
Age18 Years – 80 Years
WhereBirmingham, Alabama, United States + 32 more
SponsorReunion Neuroscience Inc
▾Tap for details
Apply